Bj. Barrett, ACETAMINOPHEN AND ADVERSE CHRONIC RENAL OUTCOMES - AN APPRAISAL OF THE EPIDEMIOLOGIC EVIDENCE, American journal of kidney diseases, 28(1), 1996, pp. 14-19
This article critically reviews existing epidemiologic studies of the
association between habitual acetaminophen use and chronic renal disea
se exclusive of neoplasia, Relevant primary studies were identified by
searching the Medline database from 1996 to March 1995. There are sev
eral case reports of analgesic nephropathy following exposure to aceta
minophen alone, but the accuracy with which other causes of this lesio
n were excluded is unclear, Three case control studies have found an i
ncreased risk (odds ratio range, 2 to 4) with habitual acetaminophen e
xposure for papillary necrosis, chronic renal failure, or end-stage re
nal disease, These studies have been open to confounding by indication
. It is also difficult to determine the risk with acetaminophen alone
given the prevalent use of analgesic mixtures in the populations studi
ed. Two prospective cohort studies have suggested an increased risk of
renal impairment or papillary calcification following regular analges
ic exposure, One of these studies was of subjects taking phenacetin-co
ntaining analgesic mixtures and the study population of the other was
too small to reach statistically significant conclusions, Recent study
results have raised the possibility that habitual acetaminophen use c
ould increase the likelihood or rate of progression of chronic renal d
isease in general, This review suggests that there is currently insuff
icient evidence to conclude that habitual use of acetaminophen as a so
le analgesic is associated with an increased risk of chronic renal dis
ease. Further research is required to examine this question, prudence
suggests that habitual use of acetaminophen should be discouraged in t
he absence of strong medical indications. (C) 1996 by the National Kid
ney foundation, Inc.